Roche Holding AG (NEO:ROG)

Market Cap	348.01B
Revenue (ttm)	99.07B
Net Income (ttm)	13.14B
Shares Out	n/a
EPS (ttm)	16.37
PE Ratio	26.48
Forward PE	12.55
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Average Volume	293
Open	20.50
Previous Close	20.45
Day's Range	20.47 - 20.50
52-Week Range	18.42 - 24.41
Beta	n/a
RSI	46.47
Earnings Date	Jul 24, 2025

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagn...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1896
• Employees: 103,249
• Stock Exchange: Cboe Canada
• Ticker Symbol: ROG

Financial Performance

In 2024, Roche Holding AG's revenue was 62.40 billion, an increase of 3.23% compared to the previous year's 60.44 billion. Earnings were 8.28 billion, a decrease of -28.01%.

Financial numbers in CHF